Executives expect a new label indication and a hoped-for easing of hospital capacity constraints to accelerate sales this ...

Relocating manufacturing would require substantial capital investment, but the timespan for the president’s new tariffs is unclear, supply chain experts said.

From the founders of BoldType comes CyberMed, a new company dedicated exclusively to MedTech cybersecurity. With a mission to ...

CEO Tim Herbert told investors the company received a civil investigative demand from the Department of Justice in January ...

Gottlieb, who led the agency during the first Trump presidency, supports a reversion to an earlier interpretation of the 21st Century Cures Act.

BD announced it would split from its biosciences and diagnostics unit, while Zimmer Biomet updated investors on its $1.1 ...

Vulnerabilities in certain Contec and Epsimed patient monitors can allow people to gain access and potentially manipulate the ...

Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s ...

The company will keep the systems on the market but is asking providers to check devices for visible cracks and return ...

CEO Tom Polen said BD will “double down on shifting our portfolio, both organically and inorganically through tuck-in M&A, ...

With the $1.1 billion acquisition, Zimmer Biomet expects its sports medicine, extremities and trauma segment will outpace ...

Job cuts in Cambridge and Plainville are the second workforce reduction planned for the facilities in the past three months.